Fundamental Data for MEDI

MedImmune, Inc. is a biotechnology company with several products on the market and a diverse product development portfolio. The company is focused on using advances in immunology and other biological sciences to develop important new products that address significant medical needs in areas such as infectious diseases, immune regulation and oncology.

# Employees: 2359

Address: One MedImmune Way,Gaithersburg,MD,USA

Phone: 301 398-0000

Fax: 301 527-4200

Website: www.medimmune.com

Email: info@medimmune.com

Sector: Medical

Industry: MED-BIOMED/GENE

Executive Officers

No Information

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 3/31/2007

Next Earnings Date(Expected): 7/19/2007

Mean EPS (Next Qtr): ($0.19)

Mean EPS (Year): $0.96

Mean Estimate(Long Term): $36.49

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 1

Shares Performance

Period	MEDI	Compare to S&P
YTD	-0.01 %	65.61 %
4 Weeks	-0.01 %	-0.01 %
12 Weeks	-0.01 %	-0.01 %

Shares Information

Analyst Coverage: Y

Avg Volume: 3294120

Shares Outstanding: 238M

Market Cap: ($0.01)M

52 Week High: $57.97

52 Week Low: $25.28

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 6/5/2000 MEDI split by factor of 3.000

Earnings Performance

EPS Growth in Last Quarter: 32.00 %

EPS Growth in Last Year: 186.96 %

Sales Growth in Last Quarter: 8.72 %

Sales Growth in Last Quarter: 15.42 %

Financials

Qtr Book Value: ($0.01)

Cash Flow/Share: ($0.01)

Change in Payout Ratio: 0.000

Price/Sales: -0.010